Study details
Enrolling now
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
University of Alabama at Birmingham
NCT IDNCT06989320ClinicalTrials.gov data as of Apr 2026
Target enrollment
80
Study length
about 6.6 years
Ages
18–80
Locations
2 sites in AL, TX
What this study is about
This trial is testing if people with kidney stones have increased oxalate production. Participants will follow a low-oxalate diet and take supplements to measure how much oxalate their body makes.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Low-oxalate diet and glycolate dosing
- 2.Oral 13C- ascorbic acid dosing
- 3.Oral glycolate dosing
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oraltopical
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
ALIMENTARY TRACT AND METABOLISM
Drug routes
oral (Oral Capsule), topical (Topical Gel)
Body systems
Renal